The Company expects to provide further information regarding its full year 2026 financial guidance on its fourth quarter earnings call in February.

Agenus Inc. , a leader in immuno-oncology innovation, today announced that France's National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national treatment protocol ...

While Congress debates bringing back Affordable Care Act subsidies , many Americans have already made life-altering decisions ...

M gross proceeds raised from pre-existing investors, providing capital runway into 2027All nine investors that were offered ...

Explore Medicaid waivers, learn about eligibility criteria, and discover the various types, including home and ...